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Executive Summary 
 The usage of essential oils for holistic and medicinal benefit has been a practice used in 
countries around the world for centuries.  Recently, there has been a notable rise in popularity in 
the usage of essential oils, with more people becoming interested in their properties for not only 
aromatherapy use, but for medicinal benefit as well. People are taking the time out to research and 
understand that there are alternatives to medical treatment besides traditional pharmaceuticals, and 
essential oils are one of them.  The oils address a variety of medical conditions--from anxiety and 
depression, to pain, nausea and vomiting, insomnia and so many other conditions. One example is 
lavender oil, which is known for its properties in promoting “spiritual relaxation, for therapeutic 
purposes (to build physical and emotional well-being), and for regulation of sleep disorders” 
(Ozkaraman et al, 2018). A population of focus that would significantly benefit from the usage of 
essential oils is cancer patients, most specifically cancer patients in the outpatient setting 
undergoing chemotherapy. Some of the most common side effects of chemotherapy include nausea 
and vomiting, pain, anxiety, depression, and insomnia and patients report that these side effects 
are often debilitating and significantly affect their quality of lives during this time in a negative 
manner.   
 The proposed intervention would be incorporating essential oil aromatherapy use into 
practice in the outpatient setting in managing the side effects of chemotherapy and educating 
patients on usage in their homes after treatment.  The goal would be to optimize essential oil use 
and to reduce the dependence on pharmaceuticals alone in managing these side effects, while 
taking a holistic approach in making patients feel whole and cared for emotionally and mentally, 
apart from just physically. By doing this, patients will feel more involved in their care and have 
greater satisfaction and outcomes. This approach gives patients the autonomy they deserve in their 
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medical decisions and allows for healthcare providers to do what is best for the patient according 
to the patient’s standards and not just the healthcare system’s standards.   
I. Rationale for the Project 
The current practice today in oncology medicine is for providers to prescribe opioid 
analgesics for acute and chronic pain management, controlled prescription antiemetics for nausea 
and vomiting, and other controlled mood-stabilizing agents or tranquilizers for conditions 
including anxiety, depression, and insomnia.  According to the American Cancer Society, 
“opioids should be prescribed and used with great care” for reasons including that “some pain 
medications may interfere with other medications” and “pain medicines may affect people 
differently” (2019). Additionally, “taking opioids… while taking tranquilizers may cause 
problems and can lead to overdoses and symptoms like weakness, trouble breathing, confusion, 
anxiety, or more severe drowsiness or dizziness” (American Cancer Society, 2019).  With this 
being said, an ethical concern is raised in regards to the safety of these medications being 
prescribed.  If the American Caner Society has these things posted on a national website, why are 
they not being made publicized in clinical practice or being openly discussed with patients? 
Additionally, the question arises as to whether or not patients are being given a choice in regards 
to the type of care they would like to receive and if alternative treatments are being presented as 
options or not? 
 The question for healthcare professionals is whether or not beneficence is truly being 
taking into consideration when failing to present care options to patients and pushing for the 
healthcare system’s recommendations rather than respecting the patient’s autonomy?  All of 
these concerns present the case that patients are not being veraciously presented with treatment 
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options for their care, and this is a major concern.  To act in addressing this concern, patients in 
the outpatient setting undergoing chemotherapy treatment should be educated on the options 
available for their care in addressing the side effects of chemotherapy, including both 
conventional and alternative treatments with the risks and benefits of both explained. This will 
be achieved through handouts with information on the alternative treatments (essential oil 
aromatherapy) with visual demonstrations. 
I.1.  Project Goals 
 This project was supposed to have been an implementation project with the goal of 
trialing the intervention in practice, ideally in an outpatient cancer clinic with patients actively 
undergoing chemotherapy.  However, due to restrictions with COVID-19, this was not feasible 
and this project became a benchmark project.  Though the trial was unable to be actively 
conducted, the goal of the project was switched from proving the effectiveness of essential oils in 
the clinical setting to educating healthcare professionals on the effectiveness of essential oils in 
everyday use and planning for future use in both the inpatient and outpatient settings with the 
help of nursing leaders. 
II. Literature Synthesis 
During the course of study in researching this topic, there have been many scholarly 
articles and trials that have been conducted all supporting the effectiveness of essential oils in 
managing the most common side effects of chemotherapy.  Due to the nature of the intervention, 
the majority of the trials are randomized controlled trials, which have provided significant 
evidence supporting the oils in practice.  For example, a study by Ozkaraman et al. (2018) trials 
the use of lavender oil in addressing sleep quality and anxiety in patients undergoing 
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chemotherapy, comparing lavender oil as the control and tea tree and no intervention as the 
placebos. The study concludes that patients reported an improved quality of sleep and reduced 
incidence of anxiety with lavender oil that was significantly lower than that of the placebo 
groups of no intervention and tea tree oil.  Another study by Shady et al. (2019) trials the use of 
lavender oil patches on cancer patients, and concludes that lavender oil significantly reduces the 
incidence of anxiety and improves sleep quality.  Lua et al. (2015) conducts a study in an 
outpatient clinic with patients undergoing chemotherapy for Breast Cancer and concludes that 
cancer-induced nausea and vomiting was significantly lower among patients who received ginger 
essential oil than that of the placebo group of ginger fragrance oil.  
Erturk and Tasci (2021) compares the use of conventional drugs with peppermint oil for 
chemotherapy-induced nausea and vomiting.  The trial concludes that peppermint oil combined 
with antiemetics significantly reduces the incidence of nausea and vomiting in patients 
undergoing chemotherapy.  Jafarimanesh et al. (2020) also details the usage of peppermint oil in 
managing nausea, vomiting, and anorexia in patients undergoing chemotherapy.  It concludes 
that peppermint oil as a complement to antiemetics significantly reduces the incidence the 
incidence of nausea, vomiting, and anorexia in patients undergoing chemotherapy.  Lastly, Dilek 
and Necmiye (2020)’s systemic review concludes that essential oil aromatherapy practices are 
effective in managing various symptoms of chemotherapy, including pain, insomnia, anxiety, 
depression, nausea and vomiting, and general health status.   
III. Stakeholders 
 For this benchmark project, the stakeholders are slightly shifted from those of an 
implementation project. As previously stated in the project goals, those included in the project 
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are healthcare professionals at the clinical level and nursing leaders. The reason for this is that by 
educating clinical staff about the benefits and usage of essential oils, the horizon of knowledge is 
expanded and the likelihood of incorporating essential oils into other practices of nursing and 
even in one’s home life is increased.  By including nursing leaders as stakeholders in the 
benchmark project, plans for future development and inclusion of essential oils and other 
complementary and alternative treatments are established and support and engagement are 
obtained.  In looking at ahead for future plans, stakeholders would also include oncology clinic 
staff including nurses and unlicensed assistive personnel, in addition to providers, nursing 
leaders, and pharmacy personnel.  Before presenting the request for approval, it is necessary to 
collect scholarly evidence as it will provide an effective case when presenting the topic for 
approval. Assessing costs and collecting information on products and supplies needed for the 
implementation, which includes cotton balls and essential oils that will be used is also key in 
being up front about costs and expectations.  This group of patrons are key in gaining the 
necessary approval (from administration and providers), for ensuring training purposes (clinical 
staff), and for ensuring that the necessary equipment and supplies will be available (pharmacy 
personnel).   
IV. Implementation 
Once all of the necessary approval has been granted, supplies are gathered, and training 
has been completed, it is appropriate to implement the plan.  Nursing staff who are trained will 
assess patients receiving chemotherapy prior to each session; patients who report previously 
having side effects including nausea, vomiting, pain, and anxiety during treatment will be offered 
the alternative treatment (essential oil aromatherapy).  The oils that will be used for the trial are 
Lavender oil for anxiety and pain, Ginger or Peppermint oils for nausea and vomiting, and 
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Orange oil for overall mood uplifting.  Patients who choose to participate have the option of 
utilizing the essential oil in conjunction with conventional treatments in lowered doses than 
usual, or they may opt to solely use the aromatherapy treatment.  Patients will be assessed for the 
presence of severe lung or respiratory conditions, or allergies to the oils being used, which would 
contraindicate them from participating.  Patients will be given a pamphlet and then educated on 
the purpose of the oils and the methods of administration, which will involve the solution being 
applied to a cotton ball and given to patients to inhale at various intervals.  A scale will be used 
prior to starting treatment to assess the presence of the symptoms and then assessed again at 
various intervals throughout therapy, with a follow up assessment at the end.  Patient data will be 
collected in phases through the various trials, which will be detailed later, and this data will be 
further evaluated by phase and revised as needed. 
V. Timetable/Flowchart 
The planning/approval phase is a two-week phase that encompasses collecting necessary 
data that supports the usage of essential oil aromatherapy in managing the side effects of 
chemotherapy. It is also important to consider risks and benefits of the intervention, appropriate 
timelines and duration, and to collectively prepare and present all of this information to the 
designated stakeholders.  Once the intervention is approved, a starting timeline must be set and 
the necessary supplies must be collected an ensured that cost will fit with the approved budget. 
Assuming that the intervention has been approved, at least one week should be set aside prior to 
intervention to allow for collection of necessary supplies to be gathered or ordered, and to 
discuss training and teaching for staff who will be administering the treatment in the clinic 
setting.  This training will include proper technique in preparing the solutions, contraindications 
to the intervention, which oils are appropriate for specific conditions, proper education to be 
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given to patients, and follow up assessments. In addressing the phase approach, the lower risk 
patients should be included in the trial first—those with the least terminal cancers, earlier stages, 
and fewer comorbidities.  This phase will be trialed for four weeks and results will be evaluated 
during a one-week assessment period, if results are positive with essentially no complications, 
then moderate to high-risk patients (with more advanced and terminal cancers and more 
comorbidities) can be trialed for another four-week trial.  Lastly, evaluation will last for one 
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VI. Data Collection Methods 
Data collection will consist of data that is collected from the different phases of the trial 
with a week-long assessment period in between phases.  Prior to administration of the 
intervention, and after consent has been obtained with necessary patient education, a scale will 
be used to assess the presence of the symptom burden (nausea, pain, anxiety, depression) on a 
zero to ten scale, with zero being the absence of symptoms and ten being the most severe 
symptom burden.  This scale will be repeated at various intervals throughout therapy, to reassess 
the presence for the presence of symptom-burden during the intervention with a follow up 
assessment and patient statement of subjective feelings at the end.  This data will be recorded in 
the electronic chart and the ratings will be reviewed at the conclusion of the first phase during 
the week-long assessment period and will then be recorded onto spreadsheets for analysis to 
determine the effectiveness and changes that need to be made for the next phase.  The necessary 
changes will be implemented in the second phase and the collective data from both phases will 
be analyzed for future use, which will provide feedback on the effectiveness of the intervention. 
VII. Cost-Benefit Discussion 
Costs of supplies include lavender oil, at about $147 per 33.3-ounce bottle, ginger oil at 
about $332 per bottle, orange oil at $17, and peppermint oil at about $69; if three bottles of each 
product are purchased quarterly, it would cost $1,695 per quarter and per year $6,780 (New 
Directions Aromatics, 2021).  If patients utilize the oils rather than antiemetics, analgesics, and 
anxiolytics, the number of drugs needed to be supplied would be decreased, thus reducing the 
drug budget.  If patients instead choose to use the oils as a complement to the conventional 
ESSENTIAL OIL USAGE IN MANAGING CHEMOTHERAPY SIDE EFFECTS 
drugs, it would also decrease the usage and need for these drugs in that dosages would be 
decreased and a would still reduce the required supply.  This would provide benefits to the 
hospital facility in that costs are reallocated and there will be less money in the budget allotted to 
controlled substances due to decreased demand, and more money is freed up for the essential oils 
to be purchased.  This also provides benefits to patients in that they are being provided with more 
autonomy in their care and are being care for holistically, which then provides for greater patient 
satisfaction and thus greater reimbursement.   
VIII. Overall Discussion and Results 
As detailed before, the project was unable to be implemented into practice due to the 
restrictions with COVID-19.  In discussing the success of the project, some strengths were that 
through the limitations with COVID, I was able to speak with other nurses and healthcare 
professionals within my current facility on the benefits of essential oils and I was able to educate 
them on proper use and application.  I was also able to establish a relationship with the Associate 
Chief Nursing Officer at my current facility, who is a Certified Aromatherapy Nurse in regards 
to my current project and discussed future plans for implantation in the future, which is 
promising.  Limitations were the inability to physically implement the intervention in practice, 
which did not allow for evidence to be collected on intervention in practice. However, through 
these interventions, I was able to discover and draw the conclusion that there are a number of 
people interested in learning about the usage of essential oil aromatherapy and that it is a 
growing area. 
Recommendations 
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The project was not able to be implemented into practice as planned, but the successes 
were the teaching that was done as an alternative and the relationship that was established with 
nursing administration in regards to the project for future plans.  The next step will be 
implementation when administration feels that things are at a better point in terms of COVID, 
which will ultimately allow for the proper research and trial data.  This will be accomplished by 
continuing to update research data for the project regularly and remaining in contact with the 
administrative contacts in planning for a trial launch date.  As a future MSN-prepared nurse, I 
would recommend persistence and patience in the mist of the trials and an attitude of optimism 
for the future.  There will be many trials faced in the future, but this approach is key in 
addressing them.  For my current facility, I would recommend taking into consideration the idea 
of educating clinical staff throughout the hospital about the usage of essential oil aromatherapy 
to prepare nurses for future plans of implementing essential oils.  For patients and leadership, 
recommendations would be to research essential oil therapy to become more familiar and 
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